Merck has other promising candidates in its late-stage pipeline, such as enlicitide decanoate/MK-0616, an oral PCSK9 ...

Moderna now anticipates ending 2025 with cash and cash equivalents worth $8.1 billion, up from its previous forecast of ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

Ms Indranee was speaking on a motion expressing regret at Mr Singh’s conduct. Read more at straitstimes.com. Read more at ...

TBG is an actively managed fund comprised of 30-40 U.S. stocks with solid track records of increasing dividends. See why the ...

The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite.

These five Dogs of the Dow may be the perfect play for 2026 for growth and income investors wary of volatility and a ...

Dow Jones Industrial Average, Chevron Corp, Coca-Cola Co, Merck & Company Inc. Read 's Market Analysis on Investing.com ...

An Ogun State customary court sitting in Ijebu Aiyepe has nullified the sale of portions of land belonging to the late Chief ...

Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these fresh ...

Merck (MRK) is back in focus after a trio of recent developments, including an upcoming J.P. Morgan Healthcare Conference ...

Healthcare dealmakers are heading to San Francisco this weekend betting on a new wave of mega-mergers in 2026 that could ...